Asymchem, a global pharmaceutical CDMO, has made strides in large-scale peptide drug production by achieving fully automated manufacturing. The company overcame significant technical hurdles, including equipment scale-up and automation of the formulation system.   To address equipment scale-up, Asymchem’s Chemical Engineering Department employed advanced simulation techniques and experimental validation to optimize the design of solid-phase synthesizers. The newly designed structure, currently...